The OPPA, a district branch of the American Psychiatric Association, is a statewide medical specialty organization whose more than 1,000 physician members specialize in the diagnosis, treatment and prevention of mental illnesses, including substance use disorders.
The State Medical Board of Ohio has rescinded current office-based opioid treatment rules and has issued new medication-assisted treatment rules which will be effective on Tuesday, April 30:
The Buprenorphine and MAT TTT Program, hosted in partnership by the American Psychiatric Association (APA) and Providers Clinical Support System (PCSS), is a two-day program hosted in Washington, DC that offers an in-depth training to DEA-X waivered psychiatrists who are currently prescribing buprenorphine to patients and are interested in serving as a regional buprenorphine trainer.
OhioHealth’s commitment to address the Behavioral Health needs of our communities included the development of an ACGME Psychiatry Residency Program. We are excited to report that on March 15th, 2019 the National Resident Matching Program (NRMP) announced match results
Earlier this week, OPPA President, William J. Resch, DO, sent a letter of support to the Chair and members of the House Civil Justice Commitee expressing OPPA's support of House Bill 61, which would exempt certain health provider personal information from public records. Read More
(COLUMBUS, Ohio)— Ohio Governor Mike DeWine today unveiled his proposed executive budget for fiscal years 2020-2021, which is structurally balanced and does not include an increase in taxes. Read More
May 8, 2019
May 13, 2019